Menu
- SITCM Overview
- Why Us?
- Prospective Students
- Current Students
- Teaching Clinic
July 22, 2019
| General Information | |
| Duration | 1 semester |
| Level | Year 2, Semester 1 |
| Unit Weighting | Unit Credit Points: 10 credit points Total Course Credit Points: 320 credit points |
| Student Workload | Number of timetabled hours per week: 4 Number of personal study hours per week: 6 Total workload hours per week: 10 |
| Prerequisites | TCM106 TCM Diagnosis & Clinical Theory; CHM108 Chinese Herbal Medicine and Formulae 1 |
| Academic Details | |
| Description | This unit complements and extends the study of CHM108 Chinese Herbal Medicine and Formulae 1 completed earlier in the course and provides additional information on herbal categories for integration into the student’s knowledge of Chinese herbal substances. This unit aims to consolidate the student’s developing understanding and familiarity with the full spectrum of medicinal substances. The unit also introduces the student to TCM herbal formulae (as a pre-requisite for CHM208 Chinese Herbal Medicine and Formulae 3 which is studied later in the course). Students study the historical development, principles of formulae construction, classification, components, functions and indications of Chinese herbal formulae theory and practice. A total of 120 (minimum) commonly used medicinal formulae are studied throughout this unit (and CHM208). For each formula category, students examine and explore the formulae modification, preparation, administration, and multi-cultural/multi-racial issues that may affect its application. Throughout the unit, students learn about restricted and scheduled herbs and their use in accordance with Australian regulations and the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP) including appropriate reporting of adverse events and referral when necessary. |
| Learning outcomes | On successful completion of this unit students will be able to: a. Describe the nomenclature (in Pinyin and/or Chinese characters, their scientific name and common English name if applicable), the characteristics, the properties, channel tropism, functions, therapeutic effects, dosage range, and special preparation requirements for herbal substances. b. Evaluate the cautions, contraindications, compatibility, incompatibility, and toxicity for commonly used Chinese medicinal substances. c. Demonstrate knowledge of and familiarity with regulations and guidelines about restricted schedules of drugs, endangered species, reporting of adverse events, and referral to other medical practitioners in simulated settings. d. Explain the historical development of TCM formula theory and its principles of construction. e. Compare the preparation, compositions, principles for combining substances, main functions, indications, applications, administration, contraindications and modifications for the main formulas in each category. |
| Assessment | Mock Practical Test (5%) Practical Test (25%) Quiz (20%) Final Examination (50%) |
| Prescribed Textbooks/Readings | * The prescribed and recommended readings are subject to annual review.
Bensky, D., Clavey, S., Gamble, A., &Stoger, E. (2015). Chinese herbal medicine: Materia medica (3rd ed.). Seattle, Wash.: Eastland Press. Bensky, D., &Barolet, R. (2009). In Scheid V. (Ed.), Chinese herbal medicine: Formulas & strategies (Rev. ed.). Seattle, WA: Eastland Press. Chan, H. C., Chang, R. C. C., Ip, A. K. C., Chiu, K., Yuen, W. H., Zee, S. Y., & So, K. F. (2007). Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma. Experimental Neurology, 203(1), 269-273. Chan, S. W. (2012). Panax ginseng Rhodiola rosea and Schisandra chinensis. International Journal of Food Sciences and Nutrition, 63(sup1), 75-81. Chinese Medicine Board of Australia. (2020, June 30). Guidelines for safe practice of Chinese herbs medicine. https://www.chinesemedicineboard.gov.au/Codes-Guidelines/Guidelines-for-safe-practice.aspx Chinese Medicine Board of Australia. (2020). Nomenclature compendium of commonly used Chinese herbal medicines. https://www.chinesemedicineboard.gov.au/Codes-Guidelines/Guidelines-for-safe-practice.aspx Hussain, T., Tan, B. E., Liu, G., Oladele, O. A., Rahu, N., Tossou, M. C., & Yin, Y. (2016). Health-promoting properties of Eucommia ulmoides: A review. Evidence-Based Complementary and Alternative Medicine, 2016 (Article ID 5202908), 9 pages. Hsu, L. M., Huang, Y. S., Tsay, S. H., Chang, F. Y., & Lee, S. D. (2006). Acute hepatitis induced by Chinese hepatoprotective herb, xiao-chai-hu-tang. Journal of the Chinese Medical Association, 69(2), 86-88. John K.Chen &Tina T. Chen (2009). Chinese Herbal Formulas and Applications. LA: Art of Medicine Press. Lin, C. J., Su, Y. C., Lee, C. H., Li, T. C., Chen, Y. A., & Lin, S. J. S. (2013). Bai-hu-tang, ancient Chinese medicine formula, may provide a new complementary treatment option for sepsis. Evidence-Based Complementary and Alternative Medicine, 2013 (Article ID 193084), 8 pages Mathew, M., & Subramanian, S. (2014). In vitro evaluation of anti-Alzheimer effects of dry ginger (Zingiber officinale Roscoe) extract. Indian Journal of Experimental Biology, 52(6):606-12. Rokot, N. T., Kairupan, T. S., Cheng, K. C., Runtuwene, J., Kapantow, N. H., Amitani, M., … & Inui, A. (2016). A role of ginseng and its constituents in the treatment of central nervous system disorders. Evidence-Based Complementary and Alternative Medicine, 2016 (Article ID 2614742), 7 pages. doi:10.1155/2016/2614742 Tsai, D. S., Chang, Y. S., Li, T. C., & Peng, W. H. (2014). Prescription pattern of Chinese herbal products for hypertension in Taiwan: a population-based study. Journal of Ethnopharmacology, 155(3), 1534-1540. |
ABN 30 100 578 836
CRICOS provider number 01768K
TEQSA provider number PRV12177
RTO Code: 5143